|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 706 JPY | -0.56% |
|
+2.92% | +24.51% |
Oncolys BioPharma Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was JPY 63.04 million compared to JPY 426.15 million a year ago. Net loss was JPY 868.76 million compared to JPY 570.57 million a year ago.
Basic loss per share from continuing operations was JPY 50.16 compared to JPY 32.92 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +24.51% | 95.81M | |
| -3.79% | 87.06B | |
| +1.45% | 40.25B | |
| -15.94% | 31.09B | |
| +52.66% | 24.74B | |
| -14.50% | 15.91B | |
| -9.12% | 11.96B | |
| -14.38% | 11.92B | |
| -42.56% | 11.61B | |
| +4.87% | 8.73B |
ONCOLYS BIOPHARMA INC. 
